L. Clavier1, V. Maffre1, A. Cambier2, T. Flenet2, L. Diop1 ¹ ANS Biotech, Riom, France² Etisense SAS, Lyon, France Safety Pharmacology Society Annual Meeting, Virtual, 2021 Abstract Opioid drugs have some adverse events such as respiratory depression. Opioid-induced...
S Baudet¹, R Fares², J Vial¹, M Ravaz¹, V Roger¹, C Bory¹, T Flénet² ¹ Charles River Laboratories France Safety Assessment SAS, Lyon, France² Etisense SAS, Lyon, France Safety Pharmacology Society Annual Meeting, Virtual, 2021, 06/10 Abstract Simultaneous assessment...
PENARD L², FLENET T¹, EYNARD C¹, BOUILLON C¹, BORY C², BAUDET S², MARSDEN E². ¹ ETISENSE SAS, Lyon, France² Charles River Laboratories France Safety Assessment SAS, Lyon, France. Society for Birth Defects Research & Prevention 61st Annual Meeting June 24–July 1,...
SIMON C¹, EYNARD C¹, FLENET T¹, PENARD L², BORY C², BAUDET S², MARSDEN E². ¹ ETISENSE, Lyon, Rhône-Alpes, France² Charles River Laboratories France Safety Assessment SAS, Saint-Germain-Nuelles, Rhône-Alpes, France. Society for Birth Defects Research & Prevention...
Raafat P. FARES¹, Alexia BOIRE², Charles EYNARD¹, Timothé FLENET¹ ¹ ETISENSE SAS, R&D department, 60A avenue Rockefeller, 69008 LYON France ² Université de Lyon, Univ. Claude Bernard Lyon 1, Master in Integrative Biology and Physiology, 43 Bd du 11 Novembre 1918,...
Timothé Flenet1, H. Barret2, E. Chastel2, A. Momtaz2, C. Eynard1 and C. Boixel2 1 R&D, ETISENSE SAS, Lyon, France2 Preclinical Safety, SANOFI, Alfortville, France Laboratory Animals 2019, Vol. 53 [1S] 28-203, abstracts of 14th FELASA annual congress...